ORBIMED ADVISORS LLC 13D and 13G filings for NeuroPace, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 6:30 pm Sale | 2024-09-30 | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 3,406,335 11.700% | -597,632 (-14.93%) | Filing |
| 2024-02-14 7:00 pm Sale | 2023-12-31 | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 4,003,967 15.200% | -8,314 (-0.21%) | Filing |
| 2023-02-14 4:48 pm Unchanged | 2022-12-31 | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.100% | 0 (Unchanged) | Filing |
| 2022-02-11 4:35 pm Unchanged | 2021-12-31 | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.500% | 0 (Unchanged) | Filing |
| 2021-04-29 5:17 pm Purchase | 2021-04-26 | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.800% | 4,012,281 (New Position) | Filing |